Mirae Asset Global Investments Co., Ltd. Guardant Health, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,653 shares of GH stock, worth $91,653. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,653Holding current value
$91,653% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding GH
# of Institutions
331Shares Held
116MCall Options Held
680KPut Options Held
1.66M-
Vanguard Group Inc Valley Forge, PA11.6MShares$292 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$282 Million0.01% of portfolio
-
Baillie Gifford & CO6.09MShares$153 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$113 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$112 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.56B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...